Jeffrey A. Meyerhardt, MD, MPH, FASCO – Dana-Farber Cancer Institute discusses Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702
Study results from CALGB/SWOG 80702 in stage III colon cancer – Jeffrey A. Meyerhardt MD MPH FASCO – Dana-Farber Cancer Institute @DanaFarber #coloncancer
By Editor